India offers cutting-edge, affordable care for Mycosis Fungoides and Sézary Syndrome, rare forms of Cutaneous T-cell Lymphoma (CTCL). Treatments include phototherapy, immunotherapy, chemotherapy, and biologics, with total care costs ranging from $4,000 – $10,000. In comparison, treatment can cost $45,000 – $100,000 in the USA and $15,000 – $30,000 in Thailand, making India a preferred destination for global cancer patients.
What Are Mycosis Fungoides and Sézary Syndrome?
Mycosis Fungoides and Sézary Syndrome are subtypes of Cutaneous T-cell Lymphoma (CTCL), a rare form of non-Hodgkin lymphoma that primarily affects the skin. Mycosis Fungoides typically presents as scaly patches, plaques, or tumors on the skin, while Sézary Syndrome is more aggressive and involves cancerous T-cells in the blood and widespread skin redness (erythroderma).
The exact cause of CTCL is unknown, but several risk factors include:
Types:
Stages:
Stage IA – IIA: Patches/plaques covering less than or more than 10% of skin
Stage IIB: One or more tumors
Stage III: Skin involvement with erythroderma
Stage IV: Involvement of lymph nodes, blood, or internal organs
India is increasingly favored for CTCL treatment because of:
Dr. Ankur Bahl is a senior oncologist renowned for managing complex and rare cancers including CTCL. Reasons to choose him include:
The Detailed Treatment Protocols for for CTCL Treatment in India:
PUVA (Psoralen + UVA) Therapy
Narrowband UVB Phototherapy
Topical and Oral Steroids
Immunotherapy
Chemotherapy
Targeted Therapies
Extracorporeal Photopheresis (ECP)
|
Treatment Component |
Estimated Cost (USD) |
|
Diagnostics (Biopsy, Imaging, Labs) |
$600 – $1,200 |
|
PUVA or UVB Phototherapy (Per Month) |
$500 – $900 |
|
Immunotherapy (e.g., Interferon, Retinoids) |
$1,000 – $2,000/month |
|
Chemotherapy (Per Cycle) |
$400 – $800 |
|
Targeted Therapy (Biologics) |
$1,500 – $3,000/month |
|
Photopheresis (if used) |
$2,000 – $4,000/session |
|
Hospital Stay and Supportive Care |
$800 – $1,500 |
|
Total Estimated Cost |
$4,000 – $10,000 |
|
Country |
Estimated Cost (USD) |
|
India |
$4,000 – $10,000 |
|
USA |
$45,000 – $100,000 |
|
Thailand |
$15,000 – $30,000 |
|
UK |
$40,000 – $90,000 |
India remains a trusted destination for complex, rare cancers like Mycosis Fungoides and Sézary Syndrome. With a patient-first approach, modern therapies, and affordable pricing, India ensures compassionate, comprehensive care for patients across the globe
These diseases are typically chronic but manageable with treatment. Early-stage Mycosis Fungoides often responds well to skin-directed therapies. Advanced stages, including Sézary Syndrome, may require long-term systemic treatment. While not always curable, modern therapies can significantly prolong survival and improve quality of life
Treatment can typically start within 5–7 days after your arrival. Hospitals often arrange a preliminary teleconsultation before you travel, which allows doctors to review your case, plan your workup, and shorten the time between arrival and treatment initiation.
Yes. Leading hospitals in India offer advanced phototherapy including PUVA, narrowband UVB, and extracorporeal photopheresis (ECP). These facilities are operated by skilled oncology and dermatology teams experienced in CTCL management.
Absolutely. Advanced Sézary Syndrome cases are treated with a combination of systemic immunotherapy, targeted biologics like mogamulizumab, and photopheresis where indicated. Indian centers follow global treatment guidelines and offer full-spectrum care.
Yes. International patient support teams help with medical visa documentation, airport pickup, hotel bookings, interpreter services, and on-ground logistics to ensure a smooth experience for you and your caregiver.
Yes. Indian hospitals use internationally approved medications—many of which are the exact same brands available in the West. India is also a global hub for quality generics, making life-saving treatment more accessible.
Definitely. Patients are encouraged to send diagnostic reports, pathology slides, and imaging in advance. A second opinion is provided by top specialists, and a treatment roadmap is shared before you commit to travel.